Congratulations go to U-M researcher Jun Hee Lee for receiving the 2024 Hanseong Science Award in Life Sciences from the Hanseong Son Jae-Han Scholarship Foundation. Dr. Lee received the award for his development of SeqScope, a revolutionary technology that allows comprehensive gene expression analysis within biological tissues using a single experiment. The Taubman Institute has…
The Taubman Institute has appointed a physician-researcher studying macular degeneration as the latest member of its Emerging Scholars Program. Thomas J. Wubben, MD, PhD, is an assistant professor at Michigan Medicine’s Kellogg Eye Center, where he cares for patients with diseases of the retina. Dr. Wubben is a translational-research ophthalmologist whose clinical specialization is in…
COVID-19 has generated a public health crisis that affects every household. And it’s exacerbating another widespread public health crisis that already was ongoing when the pandemic arrived: addiction and other mental health problems. During the pandemic, complications from substance use, and overdose deaths, have been increasing even faster than before. At the same time, it…
Emerging Scholar Sami Barmada, MD, PhD, has invited Dena Dubal, MD, PhD, to speak at Michigan Medicine’s Neurology/Neuroscience seminar Friday, September 25 at Noon-1 pm via Zoom. Dr. Dubal’s presentation is titled, “Mechanisms of Sex Bias in Alzheimer’s Disease: X Marks the Spot.” Whether sex chromosomes contribute to sex difference in Alzheimer’s disease (AD) is…
Earlier, less intrusive and less costly tests for Alzheimer’s disease would allow doctors to try intervention therapies earlier in the disorder’s development, in hopes of slowing or curbing progression of the disease. Taubman Scholar Henry Paulson, MD, PhD, was interviewed recently about some new blood tests making the news among dementia researchers. Read what he…
Join Michigan Medicine’s Daniel Goldstein, MD and renowned human transplantation immunology researchers October 12 at 9 am-Noon for an update on their Taubman Institute Innovation Project (TIIP) that aims to refine the use of immune-suppression drugs in solid organ transplant patients. Dr. Goldstein heads a team of three Michigan Medicine primary investigators in this TIIP,…
Studying and deciphering vision-related diseases is complicated by the delicate structure of the eye itself. While biopsies and samples from many other bodily systems are relatively easily obtained by physicians, collecting the vitreous fluid from within the eye is a more challenging task and often fails. The lack of a standardized process to collect and…
Funding from the Taubman Institute has helped a team of researchers develop a new approach to treating aggressive brain tumors. Daniel Wahl, MD, PhD, a radiation oncologist and researcher at Michigan Medicine, says an existing drug used to prevent organ transplant rejection may make radiation therapy more effective for glioblastoma patients by targeting a critical…
The Taubman Institute congratulates Donna M. Martin, MD, PhD, who was appointed chair of the Department of Pediatrics. She also became the Ravitz Foundation Endowed Professor of Pediatrics and Communicable Diseases. Dr. Martin is the Donita B. Sullivan, M.D., Research Professor of Pediatrics and Communicable Diseases, and a professor of pediatrics and human genetics in…
Imaging studies encompass scales of resolution from molecules to patients. Join us Thursday, Aug. 20 at Noon-1 pm via Zoom for this Taubman Technology Talks webinar. Gary Luker, MD, will present several different technologies to meet demands of imaging studies and computational approaches to extract quantitative imaging data from imaging studies. Dr. Luker is a…